242 related articles for article (PubMed ID: 21732230)
1. Two cases of plasmacytoid variant of urothelial carcinoma of urinary bladder: systemic chemotherapy might be of benefit.
Hayashi T; Tanigawa G; Fujita K; Imamura R; Nakazawa S; Yamamoto Y; Hosomi M; Shimazu K; Fushimi H; Yamaguchi S
Int J Clin Oncol; 2011 Dec; 16(6):759-62. PubMed ID: 21732230
[TBL] [Abstract][Full Text] [Related]
2. Invasive urothelial carcinoma, lymphoma-like/plasmacytoid variant, successfully treated by radical cystectomy with adjuvant chemotherapy: a case report.
Ohtaka M; Kawahara T; Kumano Y; Maeda Y; Kondo T; Mochizuki T; Ishida H; Hattori Y; Teranishi J; Miyoshi Y; Yumura Y; Yao M; Inayama Y; Uemura H
J Med Case Rep; 2016 Mar; 10():48. PubMed ID: 26951070
[TBL] [Abstract][Full Text] [Related]
3. Preoperative chemotherapy for prostatic stromal invasive urothelial bladder cancer: comparison of oncological outcomes of male patients with cT4a disease undergoing radical cystectomy with or without preoperative chemotherapy.
Chen J; Miranda G; Cai J; Daneshmand S; Djaladat H
Scand J Urol; 2019; 53(2-3):123-128. PubMed ID: 31081431
[No Abstract] [Full Text] [Related]
4. Plasmacytoid urothelial carcinoma of the bladder.
Kohno T; Kitamura M; Akai H; Takaha M; Kawahara K; Oka T
Int J Urol; 2006 Apr; 13(4):485-6. PubMed ID: 16734884
[TBL] [Abstract][Full Text] [Related]
5. [Plasmacytoid urothelial carcinoma of the bladder: a case report].
Kawashima A; Ujike T; Nin M; Nishimura K; Miyoshi S
Nihon Hinyokika Gakkai Zasshi; 2009 Jul; 100(5):590-4. PubMed ID: 19663248
[TBL] [Abstract][Full Text] [Related]
6. [Plasmacytoid variant of urothelial carcinoma of urinary bladder: a case report].
Nomura S; Suzuki Y; Saito Y; Tanabe K; Ogushi Y; Matsuzawa I; Hamasaki T; Kimura G; Kondo Y
Nihon Hinyokika Gakkai Zasshi; 2013 Jan; 104(1):26-9. PubMed ID: 23457931
[TBL] [Abstract][Full Text] [Related]
7. Plasmacytoid variant of urothelial carcinoma: a report of a rare case.
Demellawy DE; Ahmed AD; Bora B; Bonin M
Pathol Res Pract; 2012 Sep; 208(9):561-4. PubMed ID: 22854197
[TBL] [Abstract][Full Text] [Related]
8. [Prognosis in pT3b infiltrating tumors of the bladder treated by adjuvant chemotherapy].
Sahwi A; Robert M; Delbos O; Legouffe E; Guiter J; Navratil H
Prog Urol; 1998 Dec; 8(6):1007-11. PubMed ID: 9894259
[TBL] [Abstract][Full Text] [Related]
9. Urothelial bladder carcinoma with choriocarcinomatous differentiation presenting with a false-positive pregnancy test.
Rajabi B; Khoury J; Brewer C; Goodman OB
Am J Med Sci; 2013 Sep; 346(3):256-8. PubMed ID: 23147379
[TBL] [Abstract][Full Text] [Related]
10. Retrospective analysis of the efficacy of two cycles of M-VAC neoadjuvant chemotherapy followed by radical cystectomy for muscle-invasive bladder cancer.
Kitagawa Y; Izumi K; Miwa S; Kadono Y; Konaka H; Mizokami A; Namiki M
Anticancer Res; 2013 Oct; 33(10):4497-503. PubMed ID: 24123021
[TBL] [Abstract][Full Text] [Related]
11. Outcome of urinary bladder cancer after combined therapies.
Anghel RM; Gales LN; Trifanescu OG
J Med Life; 2016; 9(2):153-9. PubMed ID: 27453746
[TBL] [Abstract][Full Text] [Related]
12. Standard or accelerated methotrexate, vinblastine, doxorubicin and cisplatin as neoadjuvant chemotherapy for locally advanced urothelial bladder cancer: Does dose intensity matter?
Pouessel D; Chevret S; Rolland F; Gravis G; Geoffrois L; Roubaud G; Terrisse S; Boyle H; Chevreau C; Dauba J; Moriceau G; Alexandre I; Deplanque G; Chapelle A; Vauleon E; Colau A; Audenet F; Grellety T; Culine S
Eur J Cancer; 2016 Feb; 54():69-74. PubMed ID: 26724422
[TBL] [Abstract][Full Text] [Related]
13. Significance of lymphovascular invasion in organ-confined, node-negative urothelial cancer of the bladder: data from the prospective p53-MVAC trial.
von Rundstedt FC; Mata DA; Groshen S; Stein JP; Skinner DG; Stadler WM; Cote RJ; Kryvenko ON; Godoy G; Lerner SP
BJU Int; 2015 Jul; 116(1):44-9. PubMed ID: 25413313
[TBL] [Abstract][Full Text] [Related]
14. [A case of micropapillary bladder carcinoma].
Matsumura E; Ashikari A; Tasaki S; Kato S; Ashimine S; Machida N; Toyama H; Oshiro Y; Saito S
Hinyokika Kiyo; 2012 Jun; 58(6):279-82. PubMed ID: 22874506
[TBL] [Abstract][Full Text] [Related]
15. [Neoadjuvant chemotherapy in muscular invasive bladder cancer: Complications and consequences with cystectomy].
Benadiba S; Gauthier H; Ploussard G; Mongiat-Artus P; Froger L; Basset V; Pashootan P; Chartier E; Dadoun D; Jacob F; Ravery V; Culine S; Desgrandchamps F
Prog Urol; 2015 Jul; 25(9):549-54. PubMed ID: 26022236
[TBL] [Abstract][Full Text] [Related]
16. High-grade invasive urothelial carcinoma with focal plasmacytoid differentiation successfully treated by transurethral resection followed by chemoradiotherapy.
Kawahara T; Oshiro H; Sekiguchi Z; Ito H; Makiyama K; Uemura H; Kubota Y
Int J Urol; 2011 Dec; 18(12):851-3. PubMed ID: 22004222
[TBL] [Abstract][Full Text] [Related]
17. Can patient selection for bladder preservation be based on response to chemotherapy?
Sternberg CN; Pansadoro V; Calabrò F; Schnetzer S; Giannarelli D; Emiliozzi P; De Paula F; Scarpone P; De Carli P; Pizzo M; Platania A; Amini M
Cancer; 2003 Apr; 97(7):1644-52. PubMed ID: 12655521
[TBL] [Abstract][Full Text] [Related]
18. Mixed micropapillary and trophoblastic carcinoma of bladder: report of a first case with new immunohistochemical evidence of urothelial origin.
Regalado JJ
Hum Pathol; 2004 Mar; 35(3):382-4. PubMed ID: 15017598
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy in the post-MVAC era: the case for adjuvant chemotherapy.
Lehmann J; Retz M; Stöckle M
World J Urol; 2002 Aug; 20(3):144-50. PubMed ID: 12196897
[TBL] [Abstract][Full Text] [Related]
20. Bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer.
Maarouf AM; Khalil S; Salem EA; ElAdl M; Nawar N; Zaiton F
BJU Int; 2011 May; 107(10):1605-10. PubMed ID: 20825396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
